A new study by researchers with a health system in Detroit indicates that a small, behavioral "nudge" in microbiology reporting increased de-escalation and discontinuation of unnecessary broad-spectrum antibiotics in pneumonia patients. The results were reported in Open Forum Infectious Diseases.
"Our results justify consideration for revised recommendations from WHO and wider use of bedaquiline," the authors write.
In what appears to be an underreported outbreak, officials with Public Health England (PHE) yesterday in Eurosurveillance detailed 118 laboratory-confirmed cases of high-level azithromycin-resistant Neisseria gonorrhoeae, noting that cases emerged among heterosexuals in Leeds but then spread across England and into networks of men who have sex with men (MSM).
CARB-X is adding another diagnostic system to its growing portfolio of products targeting drug-resistant bacteria.
In a first for a Japanese company, CARB-X, a public-private collaboration that supports companies to combat antimicrobial resistance, has awarded Shionogi, of Osaka, $4.7 million to support the development of a novel beta-lactam antibiotic with potent activity against the worrisome superbugs that produce carbapenemase, including BL/BLI-resistant carbapenem-resistant Enterobacteriaceae (CRE), CARB-X said in a news release today.
A new surveillance report from the European Centre for Disease Prevention and Control (ECDC) shows that the tuberculosis (TB) incidence rate in Europe is declining by an average of 4.3% a year, the fastest decline in the world compared with other regions. But officials warn that it's not falling fast enough to achieve the World Health Organization (WHO) goal of TB elimination in Europe by 2050.
After only a handful of reports released earlier this month, Saudi Arabia's Ministry of Health (MOH) confirmed six new cases of MERS-CoV over the weekend.
Days after the Centers for Disease Control and Prevention (CDC) said kratom, a plant used as an opioid substitute, was behind a multistate outbreak of Salmonella illness, the US Food and Drug Administration (FDA) announced that Botany Bay, Enhance Your Life, and Divinity by Divinity Products Distribution of Grain Valley, Mo., agreed to stop selling all products containing kratom, and voluntarily destroyed a high vo
A systematic review of treatments for Clostridium difficile infection (CDI) yesterday in Infection Control and Hospital Epidemiology concludes that the most cost-effective treatment remains unclear.
Italian scientists this week reported detecting the MCR-1 colistin-resistance gene in 26 Escherichia coli isolates among more than 19,000 Enterobacteriaceae that they tested as part of surveillance efforts in Romagna in northern Italy.